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Comparison of Direct Iliofemoral Stenting With Staged Stenting After AngioJet Rheolytic Thrombectomy in Patients With Acute Deep Vein Thrombosis
Guang Liu, Weimin Li, Xinwu Lu, Mier Jiang. Shanghai 9th People's Hospital
Objectives: Early percutaneous rheolytic thrombectomy (RT) can potentially decrease the risk of post-thrombotic syndrome (PTS) by restoring venous patency and preserving valvular function by rapid clot remove. Direct iliofemoral stenting or staged stenting with catheterdirected thrombolysis (CDT) after AngioJet RT is still a matter of debate. This study was undertaken to compare the efficacy and treatment outcomes of patients with acute proximal deep vein thrombosis (DVT) of the lower limb accompanied with iliofemoral stenosis who underwent direct or staged stenting with CDT after RT.
Methods: Ninety-one patients with acute proximal DVT of the lower limb who were diagnosed by ultrasound imaging were divided into two treatment groups: one group received direct stenting after RT, and the other received staged stenting after RT+CDT. Comparisons were made with regards to the treatment outcome between the two groups. Venous Registry Index was used to evaluate the postprocedural patency, and PTS was assessed using the Villalta scale.
Results: Forty-six patients in direct group and 45 in the staged group were followed up for 1 year. The technical success was 100% in both groups, without any 30-day mortality. Recurrent DVT was occurred in two patients in direct group.VRI changed from 11.68 6 1.92 preoperatively to 3.21 6 1.44 postoperatively in the direct group and from 12.17 6 2.29 to 2.36 6 1.19 in the staged group. The thrombolysis rate was 81.50 6 5.76 and 85.67 6 3.84 in the direct and staged groups, respectively (P < .01; Table I ). There were no differences in complications, thrombus score, and VRI between the two groups. Immediate (24 hours) improvement in clinical symptoms in direct and staged groups was achieved in 42 (81%) and 33 (72%) cases, respectively (not significant). Significant reductions in hospital lengths of stay were noted in the direct group (4.59 6 0.91) when compared to the staged group (5.8 6 1.6). The Villalta scale was 4.20 6 2.47 in the direct group and 2.13 6 1.91 in the staged group (P < .001). Primary patency rate at 1 year was 93.5% in the direct group and 97.8% in the staged group (P ¼ .323; Table II) .
Conclusions: Both direct and staged stenting are effective treatment modalities in patients with acute proximal DVT. Compared with staged, direct provides similar treatment success and significant reductions in hospital lengths of stay but with more risk of PTS at 1-year follow-up.
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Endovenous Heat-Induced Thrombosis After Radiofrequency Ablation for Varicose VeinsdWhen and Why It Happened?
Atsushi Kitagawa, Toshihiko Nagao. Ako Central Hospital, Ako, Japan
Objectives: This study was conducted to elucidate the occurrence rate, timing, and risk factors of endovenous heat-induced thrombosis (EHIT) after radiofrequency ablation (RFA) for varicose veins of lower extremities.
Methods: A single-center prospective RFA trial enrolled 224 legs in 185 patients with varicose veins (2014 to 2016), of which 162 legs in 144 patients (mean age, 67 years; 100 legs in females) had varicose veins of great saphenous vein (GSV). Postoperative assessment with duplex ultrasound imaging was conducted for all of the patients after RFA at 1, 7, 30, and 90 days. Outcome analyses included the occurrence rate, timing of EHIT based on the Kabnick classification. The univariate and multiple logistic regression analyses of EHIT risk factors were conducted in relation to age (>75 years old), female gender, CEAP Clinical class $3, adjunct procedures (stab avulsion/partial stripping), prior history of vein surgery, and GSV diameter >7.5 mm. Also, the distance between superficial epigastric vein (SEV) and saphenofemoral junction (SFJ) was measured and analyzed in association with EHIT in the latest 60 RFA cases (defined as the SEV-SFJD) with c 2 test (34 legs with EHIT vs 26 without EHIT). Results: The EHIT occurred in 44 legs (27%; EHIT class 1: 21%, class $2: 6%). EHIT was found in 12%, 21%, 5.5%, and 0.6% of legs at 1, 7, 30, and 90 days, respectively. The strong risk factors of EHIT after RFA were CEAP Clinical class $3 and GSV diameter >7.5 mm in univariate analysis, both of which were also the strong risk factors after RFA on multiple logistic regression analysis (CEAP Clinical class $3: odds ratio, 2.58; 95% confidence interval, 1.21-5.48, P ¼ .013; GSV diameter >7.5 mm: odds ratio 3.50; 95% confidence interval, 1.61-7.60, P ¼ .0015). The SEV-SFJD was 5.2 6 3.6 mm (with EHIT) and 6.5 6 2.7 mm (without EHIT), respectively. The SEV-SFJD <4.0 mm was found more in legs with EHIT (19 legs [56%] ) than those without EHIT (4 legs [15%]), with statistical significance (P ¼ .001).
Conclusions: EHIT was found mostly on day 7 after RFA for GSV. Postoperative surveillance with duplex ultrasound imaging is important to prevent thromboembolism for the patients, especially with CEAP Clinical class $3 or GSV diameter >7.5 mm. The SEV-SFJD <4.0 mm might be associated with EHIT after RFA. 
